Item Type | Name |
Academic Article
|
Structural stability of disulfide mutants of basic pancreatic trypsin inhibitor: a molecular dynamics study.
|
Academic Article
|
The role of protein-solvent interactions in protein unfolding.
|
Academic Article
|
Accessibility and order of water sites in and around proteins: A crystallographic time-averaging study.
|
Academic Article
|
Crystal structure of human thymidylate synthase: a structural mechanism for guiding substrates into the active site.
|
Academic Article
|
Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance.
|
Academic Article
|
Cooperative fluctuations of unliganded and substrate-bound HIV-1 protease: a structure-based analysis on a variety of conformations from crystallography and molecular dynamics simulations.
|
Academic Article
|
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor.
|
Academic Article
|
Design of HIV-1 protease inhibitors active on multidrug-resistant virus.
|
Academic Article
|
How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease.
|
Academic Article
|
Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.
|
Academic Article
|
Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease.
|
Academic Article
|
Design and synthesis of HIV-1 protease inhibitors incorporating oxazolidinones as P2/P2' ligands in pseudosymmetric dipeptide isosteres.
|
Academic Article
|
Contribution of Ser386 and Ser396 to activation of interferon regulatory factor 3.
|
Academic Article
|
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5.
|
Academic Article
|
Viral protease inhibitors.
|
Academic Article
|
Additivity in the analysis and design of HIV protease inhibitors.
|
Academic Article
|
Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces.
|
Academic Article
|
Structure of a phage display-derived variant of human growth hormone complexed to two copies of the extracellular domain of its receptor: evidence for strong structural coupling between receptor binding sites.
|
Academic Article
|
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways.
|
Academic Article
|
Structure-based design, synthesis, and structure-activity relationship studies of HIV-1 protease inhibitors incorporating phenyloxazolidinones.
|
Academic Article
|
Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease.
|
Academic Article
|
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
|
Academic Article
|
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
|
Academic Article
|
Hydrophobic core flexibility modulates enzyme activity in HIV-1 protease.
|
Academic Article
|
Design, synthesis, and biological and structural evaluations of novel HIV-1 protease inhibitors to combat drug resistance.
|
Academic Article
|
Extreme entropy-enthalpy compensation in a drug-resistant variant of HIV-1 protease.
|
Academic Article
|
The molecular basis of drug resistance against hepatitis C virus NS3/4A protease inhibitors.
|
Academic Article
|
Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket.
|
Academic Article
|
Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease.
|
Academic Article
|
Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.
|
Academic Article
|
Structure-based prediction of potential binding and nonbinding peptides to HIV-1 protease.
|
Academic Article
|
Covariation of amino acid positions in HIV-1 protease.
|
Academic Article
|
Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modeling.
|
Academic Article
|
Exploring the role of the solvent in the denaturation of a protein: a molecular dynamics study of the DNA binding domain of the 434 repressor.
|
Academic Article
|
Expression, purification, and characterization of thymidylate synthase from Lactococcus lactis.
|
Academic Article
|
Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.
|
Academic Article
|
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
|
Academic Article
|
Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity.
|
Academic Article
|
Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
|
Academic Article
|
HIV-1 protease inhibitors from inverse design in the substrate envelope exhibit subnanomolar binding to drug-resistant variants.
|
Academic Article
|
Structural analysis of human immunodeficiency virus type 1 CRF01_AE protease in complex with the substrate p1-p6.
|
Academic Article
|
Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
|
Academic Article
|
Human immunodeficiency virus type 1 protease-correlated cleavage site mutations enhance inhibitor resistance.
|
Academic Article
|
Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
|
Academic Article
|
Rationale for more diverse inhibitors in competition with substrates in HIV-1 protease.
|
Academic Article
|
Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
|
Academic Article
|
Structural insights into neuronal K+ channel-calmodulin complexes.
|
Academic Article
|
Structural and thermodynamic basis of amprenavir/darunavir and atazanavir resistance in HIV-1 protease with mutations at residue 50.
|
Academic Article
|
Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain.
|
Concept
|
Models, Molecular
|
Academic Article
|
Testing the substrate-envelope hypothesis with designed pairs of compounds.
|
Academic Article
|
Crystal structures of human CtBP in complex with substrate MTOB reveal active site features useful for inhibitor design.
|
Academic Article
|
HIV-1 protease-substrate coevolution in nelfinavir resistance.
|
Academic Article
|
Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease.
|
Academic Article
|
The ssDNA Mutator APOBEC3A Is Regulated by Cooperative Dimerization.
|
Academic Article
|
Structure-guided design of a high affinity inhibitor to human CtBP.
|
Academic Article
|
REdiii: a pipeline for automated structure solution.
|
Academic Article
|
Structure of the Vif-binding domain of the antiviral enzyme APOBEC3G.
|
Academic Article
|
A Direct Interaction with RNA Dramatically Enhances the Catalytic Activity of the HIV-1 Protease In Vitro.
|
Academic Article
|
Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.
|
Academic Article
|
A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
|
Academic Article
|
Structural and molecular analysis of a protective epitope of Lyme disease antigen OspA and antibody interactions.
|
Academic Article
|
Structural Determination of the Broadly Reactive Anti-IGHV1-69 Anti-idiotypic Antibody G6 and Its Idiotope.
|
Academic Article
|
Synonymous Mutations at the Beginning of the Influenza A Virus Hemagglutinin Gene Impact Experimental Fitness.
|
Academic Article
|
Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
|
Academic Article
|
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
|
Academic Article
|
Molecular Mechanism of Resistance in a Clinically Significant Double-Mutant Variant of HCV NS3/4A Protease.
|
Academic Article
|
T cell epitope engineering: an avian H7N9 influenza vaccine strategy for pandemic preparedness and response.
|
Academic Article
|
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem Antibody.
|
Academic Article
|
Assembly of human C-terminal binding protein (CtBP) into tetramers.
|
Academic Article
|
HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
|
Academic Article
|
Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
|
Academic Article
|
Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease.
|
Academic Article
|
HIV-1 Protease Inhibitors Incorporating Stereochemically Defined P2' Ligands To Optimize Hydrogen Bonding in the Substrate Envelope.
|
Academic Article
|
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
|
Academic Article
|
Optimizing the refinement of merohedrally twinned P61 HIV-1 protease-inhibitor cocrystal structures.
|
Academic Article
|
Structural Analysis of Potent Hybrid HIV-1 Protease Inhibitors Containing Bis-tetrahydrofuran in a Pseudosymmetric Dipeptide Isostere.
|
Academic Article
|
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
|
Academic Article
|
Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188.
|
Academic Article
|
NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP).
|
Academic Article
|
Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
|
Academic Article
|
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations.
|
Academic Article
|
Elucidating the Substrate Envelope of Enterovirus 68-3C Protease: Structural Basis of Specificity and Potential Resistance.
|